Chodakewitz Jeffrey 4

What Happened

• Jeffrey Chodakewitz, a member of Adicet Bio's board of directors, was granted 4,200 shares (reported as a derivative award) on 2026-06-21. The grant is reported at $0.00 per share (reported acquisition value $0.00) and is an equity award rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-21; filing date: 2026-06-23 (filed within the normal 2‑business‑day window).
• Shares granted: 4,200; reported acquisition price: $0.00; reported aggregate value: $0.00.
• Shares owned after transaction: not specified in the Form 4 filing.
• Footnote: These shares vest in full on the earlier of (i) the first anniversary of the grant date or (ii) the date of the next annual meeting of stockholders, subject to the director's continued service on the board.

Context

• This is a director compensation award (restricted equity) and does not reflect a market purchase or sale. Such grants are routine for non-employee directors and are compensatory rather than a direct signal of buying/selling intent. The award vests based on continued board service per the footnote above.